NCT06073587 - The CARDIO-TTRansform Scintigraphy Sub-study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Interventions

DIAGNOSTIC_TEST

Scintigraphy scan

Scans will be performed as specified in the arm description.

Trial Locations (5)

Columbia University Irving Medical Center, New York

Duke University Medical Center, Durham

Hospital Universitario Puerta de Hierro, Majadahonda

Cleveland Clinic Main Campus, Cleveland

Oregon Health and Science University, Portland